Back to top

Image: Bigstock

Cameco Posts Q1 Earning Beat: A Compelling Reason to Buy the Stock?

Read MoreHide Full Article

Key Takeaways

  • Cameco Q1 adjusted earnings jumped 194% as uranium sales volumes and EBITDA increased.
  • CCJ expects 2026 uranium revenues to decline about 7% due to lower delivery volumes.
  • Cameco holds long-term uranium contracts and plans capacity expansion at key operations.

Cameco (CCJ - Free Report) reported first-quarter 2026 results on Tuesday. Total revenues were up 7% year over year to CAD 845 million ($616 million). Adjusted earnings rose 194% year over year to CAD 0.47 per share or 34 cents. Cameco beat the Zacks Consensus Estimate on both counts.

In the past six months, Cameco shares have gained 26% compared with the industry’s 9.4% growth. Meanwhile, the broader Oils-Energy sector has moved up 23.3%, while the S&P 500 has climbed 9.2%.

Cameco’s 6-Month Price Performance vs. Industry, Sector & Peers

Zacks Investment Research
Image Source: Zacks Investment Research

However, Cameco has lagged peers like Ur-Energy Inc. (URG - Free Report) and Energy Fuels (UUUU - Free Report) , which have gained 41.6% and 38.9%, respectively.

Let us delve deeper into the company’s first-quarter results and long-term prospects before assessing whether to buy, hold or sell the stock.

Digging Deeper Into Cameco’s Q126 Results

Uranium production in the quarter was up 3% year over year to 6.2 million pounds. The company sold 7.8 million pounds of uranium, 13% higher than the first quarter of 2025. 

Cameco’s uranium revenues increased 15% to CAD712 million ($520 million) on higher volumes and prices. While the average U.S. dollar spot price for uranium increased 34% on a year-over-year basis, the Canadian dollar average realized price rose 2% due to the impact of fixed-price contracts compared to 2025 as well as the lagging impact of spot price changes on the portfolio
In Fuel Services, production volume was down 15% year over year to 3.3 million kgUs while sales volume rose 17% to 2.8 million kgUs. The segment reported a 1% dip in revenues to CAD 134 million ($98 million), with higher volumes being offset by a 17% decline in average realized prices. 

Cameco’s total revenues were up 7% to CAD 845 million ($616 million) reflecting improved performance of the uranium segment which helped offset lower revenues in Fuel services. 

Total cost of sales increased 4.6% to around CAD 543 million ($397 million). In the uranium segment, costs climbed 9% due to a higher sales volume partially offset by a 3% decrease in unit cost of sales. Costs in Fuel services segment increased 35% driven by the 17% increase in sales volume and a 16% increase in the average unit cost of sales. The company stated unit cost of sales could be impacted by the imposition of tariffs.

Adjusted EBITDA rose 44% year over year to CAD 509 million ($372 million). Cameco’s adjusted earnings surged 194% year over year to CAD 0.47 (34 cents) per share in the quarter. This was mainly attributed to higher revenues and stronger equity earnings from its 49% interest in Westinghouse Electric Company.

Cameco's 2026 Outlook Points to Lower Uranium Revenues

Uranium production is projected between 19.5 million pounds and 21.5 million pounds for 2026. Cameco expects uranium deliveries of 29–32 million pounds. Uranium revenues are projected in the range of CAD 2.54–2.73 billion, based on an average realized price of CAD 85–89 per pound. At the midpoint, this implies a roughly 7% year-over-year decline due to lower volumes. The fuel services segment is expected to fare better, with revenues projected at CAD 590-630 million, suggesting a 9% increase from 2025 levels. 

Cameco’s total revenue guidance for the year is CAD 3.13-3.37 billion. The midpoint suggests a 7% decline from the CAD 3.482 billion in revenues reported in 2025. 

Cameco expects its share of adjusted EBITDA from Westinghouse to be $370-$430 million for 2026.

CCJ’s Estimates Suggest Growth, Revisions Seem Mixed

The Zacks Consensus Estimate for Cameco’s earnings for 2026 has moved down over the past 60 days, while the same for 2027 has moved up, as shown in the chart below.

Zacks Investment Research
Image Source: Zacks Investment Research

The consensus estimate for Cameco’s earnings for 2026 indicates year-over-year growth of 18.5%. The same for 2027 implies growth of 57.11%.

Zacks Investment Research
Image Source: Zacks Investment Research

Cameco’s Valuation Looks Stretched

CCJ stock is trading at a forward price-to-sales ratio of 20.28 compared with the industry’s 5.48. CCJ’s Value Score of F suggests that the stock is not so cheap and a stretched valuation at this moment.

Zacks Investment Research
Image Source: Zacks Investment Research

Energy Fuels is trading higher at 22.78 while Ur-Energy is a cheaper option, trading at 4.62.

CCJ’s Long-Term Story Intact

Cameco continues to strengthen its long-term portfolio. It has long-term obligations to deliver about 230 million pounds of uranium, translating to average annual deliveries of around 28 million pounds over the next five years. In the Fuel Services segment, strong demand and elevated UF6 conversion prices have enabled Cameco to secure additional long-term contracts. Total contracted volumes now stand at roughly 83 million kgU of UF6, offering solid visibility into future revenues

Cameco’s uranium production capacity is among the largest globally, accounting for nearly 15% of worldwide output. The company is investing to expand production and capture favorable market conditions, including extending Cigar Lake’s mine life to 2036 and ramping up output at McArthur River and Key Lake toward their licensed annual capacity of 25 million pounds (100% basis).

Rising energy security concerns, geopolitical tensions and the global push for low-carbon energy continue to create structural tailwinds for nuclear power. With low-cost, high-grade assets and a diversified nuclear fuel cycle portfolio, Cameco is well-positioned to benefit from sustained growth in nuclear energy demand.

Should You Buy Cameco Stock Now?

Supported by a strong balance sheet, the company is making investments to boost its capacity to capitalize on the expected surge in uranium demand. However, new investors can wait for a better entry point, considering the premium valuation and mixed earnings estimate revisions. The stock currently carries a Zacks Rank #3 (Hold).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' 7 Best Strong Buy Stocks (New Research Report)

Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.

Click Here, It's Really Free

Published in